X-ZELL Cryoimmunostaining™ Suite to feature at Medlab Asia 2019 Singapore, February 2019 – Singaporean medical technology start-up X-ZELL will preview the production version of the world’s first slide-based, eight-channel immunostaining solution at the 2019...
X-ZELL signs research collaboration agreement with Diagnostics Development Hub X-ZELL is now officially partnering with Singapore’s DxD Hub. Singapore, December 2018 – In a move that will accelerate the company’s capabilities and scale up its...
X-ZELL CEO presenting breakthrough CEC research at EMUC18 Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has used the 2018 European Multidisciplinary Congress on Urological Cancers (EMUC18) in Amsterdam as a platform to present new insights into the...
X-ZELL taking centre stage at inaugural A*CCELERATE NOW expo Singapore, November 2018 – X-ZELL has been one of eight promising biotechnology start-ups selected to exhibit at the inaugural A*CCELERATE NOW exhibition in Singapore. The landmark event – held in a move to...
X-ZELL to present at EMUC18 Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has been invited to join the 2018 European Multidisciplinary Congress on Urological Cancers (#EMUC18) in Amsterdam next month as a plenary speaker. Dr Bhakdi’s addition to the...
X-ZELL officially incorporated in Singapore Singapore, October 2018 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, is coming to Singapore. According to X-ZELL CEO, Dr Sebastian Bhakdi, the rare cell detection specialist’s global...
